Drisdol and Osteoarthritis - a phase IV clinical study of FDA data

Summary:

Osteoarthritis is reported as a side effect among people who take Drisdol (ergocalciferol), especially for people who are female, 60+ old, also take Neurontin, and have Arthritis.

The phase IV clinical study analyzes which people have Osteoarthritis when taking Drisdol. It is created by eHealthMe based on reports of 1,686 people who have side effects when taking Drisdol from the FDA, and is updated regularly.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,740 Drisdol users. Check the latest studies of Drisdol.

What is Osteoarthritis?

Osteoarthritis (a joint disease caused by cartilage loss in a joint) is found to be associated with 1,877 drugs and 2,645 conditions by eHealthMe. Check the latest studies of Osteoarthritis.

On Jul, 11, 2026

1,686 people reported to have side effects when taking Drisdol.
Among them, 11 people (0.65%) have Osteoarthritis.

Among these 11 people:

What is the gender of people who have Osteoarthritis when taking Drisdol? *

female: 100 %
male: 0.0 %

What is the age of people who have Osteoarthritis when taking Drisdol? *

What are other drugs people take besides Drisdol? *

What are other side effects people have besides Osteoarthritis? *

Pain: 9 people, 81.82%
Pain In Extremity: 7 people, 63.64%
Neuropathy Peripheral (surface nerve damage): 6 people, 54.55%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 6 people, 54.55%
Intervertebral Disc Degeneration (spinal disc degeneration): 6 people, 54.55%
Stress And Anxiety: 6 people, 54.55%
Visual Impairment: 6 people, 54.55%
Cough: 5 people, 45.45%
Osteonecrosis Of Jaw (death of bone of jaw): 5 people, 45.45%
Osteomyelitis (infection of bone): 5 people, 45.45%

What are the existing conditions these people have? *

Sleep Disorder: 4 people, 36.36%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Depression: 4 people, 36.36%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 36.36%
Muscle Spasms (muscle contraction): 4 people, 36.36%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 36.36%
Pain: 3 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 18.18%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Drisdol and have Osteoarthritis?

- Check whether Osteoarthritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Drisdol:

Drisdol (1,740 reports)

Osteoarthritis treatments and more:

Osteoarthritis (95,654 reports)

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteoarthritis:

Osteoarthritis (1,877 drugs)

Browse all the conditions that are associated with Osteoarthritis:

Osteoarthritis (2,645 conditions)

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on ergocalciferol (the active ingredients of Drisdol) and Drisdol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.